MichaelGoode

[TimAlerts] Adam Feuerstein @adamfeuerstein AXON is completer’s analysis of a failed study. The data echo what $GSK previously disclosed, except Vivek does his analysis from Bermuda.

my2cents

[TimAlerts] AXON "The data to date warrant advancement of RVT-101 into the upcoming confirmatory phase 3 study." looking goood

Page
of 9